Clinical efficacy and safety of intravitreal injection Ranibizumab assisted 25G+ minimally invasive VRS in the treatment of severe PDR

Clinical efficacy and safety of intravitreal injection Ranibizumab assisted 25G+ minimally invasive VRS in the treatment of severe PDR

AIM:To study the efficacy and safety of intravitreal injection ranibizumab(IVR)assisted 25G+ minimally invasive vitreoretinal surgery(VRS)in the treatment of severe proliferative diabetic retinopathy(PDR). <p>METHODS: Totally 61 patients and 74 eyes were selected with severe PDR from March 201...

Full description

Bibliographic Details
Main Author:	Hui Ren
Format:	Article
Language:	English
Published:	Press of International Journal of Ophthalmology (IJO PRESS) 2017-08-01
Series:	Guoji Yanke Zazhi
Subjects:	diabetic retinopathy vitrectomy monoclonal antibody against vascular endothelial growth factor vitreous hemorrhage macular thickness
Online Access:	http://ies.ijo.cn/cn_publish/2017/8/201708027.pdf

Similar Items

Influence of preoperative intravitreal injection of Ranibizumab on perioperative VRS parameters in patients with PDR
by: Jun-Xia Lu, et al.
Published: (2017-08-01)

Persistent vitreous hemorrhage after intravitreal injection of dexamethasone intravitreal implant in patients with diabetic macular edema
by: Meng-Syuan Li, et al.
Published: (2019-01-01)

The effect of adjunctive intravitreal conbercept at the end of diabetic vitrectomy for the prevention of post-vitrectomy hemorrhage in patients with severe proliferative diabetic retinopathy: a prospective, randomized pilot study
by: Tingting Jiang, et al.
Published: (2020-02-01)

Evaluation of intravitreal ranibizumab injection as a line of treatment for chronic central serous retinopathy
by: Emad A.A Saliem
Published: (2019-01-01)

Short-term results of intravitreal ranibizumab injection in eyes with diabetic macular edema
by: Ahmed Sharaf, et al.
Published: (2015-01-01)

Effect of intravitreal injection of Ranibizumab on choroid in patients with severe NPDR with macular edema
by: Fu-Qin Du, et al.
Published: (2017-11-01)

Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema
by: Thomas BJ, et al.
Published: (2016-08-01)

Clinical observation of intravitreal injection of Conbercept treating diabetic macularedema
by: Li Jiang, et al.
Published: (2017-06-01)

Outcomes of pars plana vitrectomy for the treatment of persistent diffuse diabetic macular edema
by: Ashraf M Gad Elkareem, et al.
Published: (2018-01-01)

Effect and safety of PPV assisted by intravitreal injection of Conbercept in the treatment of PDR combined with vitreous hemorrhage
by: Chun-Shi Li, et al.
Published: (2021-09-01)

Long-term results of a single injection of intravitreal dexamethasone as initial therapy in diabetic macular edema
by: Santosh Kumar Mahapatra, et al.
Published: (2020-01-01)

Clinical study of intraocular pressure and retinal thickness affected by residual triamcinolone acetonide after vitrectomy
by: Xin Li, et al.
Published: (2018-10-01)

Clinical observation of intravitreal injection of Ranibizumab for choroidal neovascularization in patients with non- age-related macular degeneration
by: Yu-Xin Li, et al.
Published: (2016-05-01)

Efficacy of internal limiting membrane peeling for diabetic macular edema after preoperative anti-vascular endothelial growth factor injection
by: Jing Guo, et al.
Published: (2020-11-01)

Curative effect of intravitreal injection of ranibizumab combined with vitrectomy for PDR
by: Li-Xiao Shang, et al.
Published: (2019-05-01)

Effect of Intravitreal Bevacizumab Injection before Panretinal Photocoagulation on the Prevention of Macular Edema Aggravation in Proliferative Diabetic Retinopathy
by: Wungrak Choi, et al.
Published: (2020-11-01)

Comparison of Conbercept with Ranibizumab for the treatment efficiency of macular edema: a meta-analysis
by: Rui Shi, et al.
Published: (2017-12-01)

27G vitrectomy with proliferative membrane cutting <i>in situ</i> for late PDR
by: Ding-Wang Su, et al.
Published: (2018-07-01)

Effects of photodynamic therapy with Ranibizumab on visual acuity and postoperative complications in patients with PCV complicated with vitreous hemorrhage
by: Jing Yan, et al.
Published: (2018-12-01)

Effect of intravitreal injection of conbercept on neovascular age-related macular degeneration
by: Tao Li, et al.
Published: (2019-04-01)

Effect of intravitreal injection of Bevacizumab for vitreous hemorrhage in patients with proliferative diabetic retinopathy
by: Na Meng, et al.
Published: (2016-05-01)

Analysis on risk factors of early bleeding after 23G bead resection for PDR
by: Xiang Wang, et al.
Published: (2019-06-01)

Comparison between 1-week and 1-month results of intravitreal ranibizumab in diabetic macular edema
by: Mohsen A Abou Shousha
Published: (2015-01-01)

Clinical effects and safety of treating diabetic macular edema with intravitreal injection of ranibizumab combined with retinal photocoagulation
by: Yan PS, et al.
Published: (2016-04-01)

Effects of intravitreal injection Conbercept combined with 23G minimally invasive vitrectomy on PDR
by: Gui-Jun Luo, et al.
Published: (2018-07-01)

Intravitreal injection of Ranibizumab treating noninfectious uveitic macular edema
by: Hong-Bin Xie, et al.
Published: (2018-09-01)

Intravitreal Ranibizumab Therapy for Choroidal Neovascularization Secondary to Pathological Myopia: 3 Year Outcome
by: İrfan Perente, et al.
Published: (2018-04-01)

Prognostic factors of short-term outcomes of intravitreal ranibizumab in diabetic macular edema
by: I-An Lai, et al.
Published: (2017-05-01)

Evaluation of intravitreal bevacizumab as monotherapy and in combination with macular grid laser photocoagulation in diffuse diabetic macular edema
by: Gopal K Das, et al.
Published: (2018-01-01)

Changes of vitreous cytokine levels in eyes with PDR after intravitreal injection of Ranibizumab or Triamcinolone acetonide
by: Xin-Ting Wang, et al.
Published: (2020-07-01)

Choroidal Blood Flow After Intravitreal Ranibizumab in Vitrectomized and Non-Vitrectomized Eyes with Diabetic Macular Edema
by: Pessoa B, et al.
Published: (2021-10-01)

Reoperation following vitrectomy for diabetic vitreous hemorrhage with versus without preoperative intravitreal bevacizumab
by: Xuting Hu, et al.
Published: (2019-09-01)

Pars Plana Vitrectomy with Internal Limiting Membrane Peeling for Refractory Diffuse Diabetic Macular Edema
by: Mohammad-Hossein Dehghan, et al.
Published: (2010-01-01)

Comparison of vitrectomized with nonvitrectomized eyes after subtenon injection of triamcinolone acetonide to treat diabetic macular edema: Retrospective comparative Analysis of an interventional case series
by: Kang Yeun Pak, et al.
Published: (2017-01-01)

Vitrectomy and internal limiting membrane peeling with different vitreous tamponade for idiopathic macular epiretinal membrane
by: Jie Dong, et al.
Published: (2013-06-01)

Intravitreal bevacizumab (IVB) versus IVB in combination with pars plana vitrectomy for vitreous hemorrhage secondary to proliferative diabetic retinopathy: a randomized clinical trial
by: Danilo Moyses Jorge, et al.
Published: (2021-04-01)

Relationship between aqueous humor cytokine level changes and retinal vascular changes after intravitreal aflibercept for diabetic macular edema
by: Rodolfo Mastropasqua, et al.
Published: (2018-11-01)

Changes in Central Macular Thickness after Uncomplicated Phacoemulsification Surgery in Diabetic and Non Diabetic Patients
by: Sezen Akkaya, et al.
Published: (2018-04-01)

Relationship between serum level of lipoprotein (a) and central macular thickness in diabetic patients
by: Howaida E Deraz, et al.
Published: (2021-01-01)

Increased serum concentration of netrin-1 after intravitreal bevacizumab injection: is it a compensatory mechanism to counteract drug side effects?
by: Murat Okutucu, et al.
Published: (2021-05-01)